ENTRY       D08864                      Drug
NAME        Azilsartan (JAN/USAN/INN);
            Azilva (TN)
FORMULA     C25H20N4O5
EXACT_MASS  456.1434
MOL_WEIGHT  456.4501
CLASS       Cardiovascular agent
             DG01925  Renin-angiotensin system inhibitor
              DG01495  Angiotensin II receptor antagonist
             DG03231  Antihypertensive
              DG01495  Angiotensin II receptor antagonist
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
REMARK      Therapeutic category: 2149
            Chemical structure group: DG00351
            Product (DG00351): D08864<JP> D08865<US>
            Product (mixture): D10524<JP>
EFFICACY    Antihypertensive, Angiotensin II receptor antagonist
COMMENT     Treatment of hypertension
TARGET      AGTR1 [HSA:185] [KO:K04166]
  PATHWAY   hsa04020(185)  Calcium signaling pathway
            hsa04080(185)  Neuroactive ligand-receptor interaction
            hsa04270(185)  Vascular smooth muscle contraction
            hsa04614(185)  Renin-angiotensin system
METABOLISM  Enzyme: CYP2C9 [HSA:1559]
INTERACTION  
BRITE       USP drug classification [BR:br08302]
             Cardiovascular Agents
              Angiotensin II Receptor Antagonists
               Azilsartan
                D08864  Azilsartan (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               214  Antihypertensives
                2149  Others
                 D08864  Azilsartan (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01925  Renin-angiotensin system inhibitor
               DG01495  Angiotensin II receptor antagonist
                DG00351  Azilsartan
                 D08864  Azilsartan
              DG03231  Antihypertensive
               DG01495  Angiotensin II receptor antagonist
                DG00351  Azilsartan
                 D08864  Azilsartan
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D08864  Azilsartan
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01495  Angiotensin II receptor antagonist
               D08864  Azilsartan
              DG03231  Antihypertensive
               D08864  Azilsartan
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Angiotensin
                AGTR1
                 D08864  Azilsartan (JAN/USAN/INN) &lt;JP&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D08864
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08864
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08864
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01925  Renin-angiotensin system inhibitor
               DG01495  Angiotensin II receptor antagonist
                DG00351  Azilsartan
              DG03231  Antihypertensive
               DG01495  Angiotensin II receptor antagonist
                DG00351  Azilsartan
DBLINKS     CAS: 147403-03-0
            PubChem: 96025547
            ChEBI: 68850
            LigandBox: D08864
ATOM        34
            1   C8y C    22.2302  -17.2042
            2   N4y N    21.8107  -15.8755
            3   C8y C    23.6288  -17.2042
            4   C8y C    21.5309  -18.3929
            5   C8y C    22.9295  -15.0364
            6   C1b C    20.6219  -15.1762
            7   N5x N    24.1183  -15.8755
            8   C8x C    24.3281  -18.3929
            9   C8x C    22.2302  -19.5817
            10  C6a C    20.8317  -19.5817
            11  O2a O    22.9295  -13.6378
            12  C8y C    19.3632  -15.8755
            13  C8x C    23.6288  -19.5817
            14  O6a O    21.5309  -20.8404
            15  C1b C    24.1882  -12.9385
            16  C8x C    18.1744  -15.2461
            17  C8x C    19.3631  -17.2741
            18  C1a C    24.1882  -11.5399
            19  C8x C    16.9856  -15.9454
            20  C8x C    18.2443  -18.0433
            21  C8y C    16.9856  -17.3440
            22  C8y C    15.7968  -18.0433
            23  C8y C    14.5381  -17.4139
            24  C8x C    15.7968  -19.4419
            25  C8y C    14.5381  -15.9454
            26  C8x C    13.4193  -18.1132
            27  C8x C    14.6080  -20.2111
            28  N4x N    13.4192  -15.1762
            29  N5x N    15.6569  -15.1063
            30  C8x C    13.4192  -19.5118
            31  C8y C    13.8388  -13.8476
            32  O7x O    15.2374  -13.8476
            33  O6a O    12.9842  -12.7405
            34  O6a O    19.4332  -19.5645
BOND        38
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     4   9 2
            9     4  10 1
            10    5  11 1
            11    6  12 1
            12    8  13 2
            13   10  14 2
            14   11  15 1
            15   12  16 1
            16   12  17 2
            17   15  18 1
            18   16  19 2
            19   17  20 1
            20   19  21 1
            21   21  22 1
            22   22  23 1
            23   22  24 2
            24   23  25 1
            25   23  26 2
            26   24  27 1
            27   25  28 1
            28   25  29 2
            29   26  30 1
            30   28  31 1
            31   29  32 1
            32    5   7 2
            33    9  13 1
            34   20  21 2
            35   27  30 2
            36   31  32 1
            37   31  33 2
            38   10  34 1
///
